South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sanofi-aventis south africa (pty) ltd - injection - see ingredients - each vial contains rabbit anti-human thymocyte immunoglobulin 25,0 mg

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - rabbit anti-human thymocyte immunoglobulin - injection, powder, for solution - 25 mg/vial - rabbit anti-human thymocyte immunoglobulin 25 mg/vial

United States - English - NLM (National Library of Medicine)

northwind pharmaceuticals - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 50 ug - thyroid hormone drugs are indicated: as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. this category includes cretinism, myxedema and ordinary hypothyroidism in patients of any age (pediatric patients, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary) or tertiary (hypothalamic) hypothyroidism (see warnings). as pituitary thyroid-stimulating hormone (tsh) suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (hashimoto’s) and multinodular goiter. as diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland aut

United States - English - NLM (National Library of Medicine)

northwind pharmaceuticals, llc - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 25 ug - thyroid hormone drugs are indicated: 1. as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. this category includes cretinism, myxedema and ordinary hypothyroidism in patients of any age (pediatric patients, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary) or tertiary (hypothalamic) hypothyroidism (see warnings). 2. as pituitary thyroid-stimulating hormone (tsh) suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (hashimoto’s) and multinodular goiter. 3.  as diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gl

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml

United States - English - NLM (National Library of Medicine)

mylan institutional llc - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml

Canada - English - Health Canada

pfizer canada ulc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 1 g

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate is indicated in the treatment of gestational choriocarcinoma, chori-oadenoma destruens and hydatidiform mole. methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin's lymphomas. methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation . it is important to ensure that a psoriasis "flare" is not due to an undiagnosed concomitant disease affecting immune res